Skip to content
Screener

Establishment Labs ESTA Operating Cash Flow

Operating Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$8.62B+122%
AbbVie logo
AbbVieABBV
$3.83B+134%
IAR
Integra LifeSciencesIART
$22.8M+156%
Artivion logo
ArtivionAORT
-$1.27M-108%
Globus Medical logo
Globus MedicalGMED
$209.74M+169%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$6.22M-153%

Other financials

Income statement

See full
Revenue$67.5M+31.7%
Gross profit$47.7M+35.3%
Operating income-$4.3M+69.6%
Net income-$11.7M+29.2%
EPS (diluted)-$0.39+31.6%

Balance sheet

See full
Cash & equivalents$71.2M+30.2%
Total debt$263.7M+14.1%
Total equity$21.6M-5.1%
Total assets$351.9M+6.8%

Cash flow

See full
CapEx$3.7M+125%
Free cash flow-$20.3M+0.6%

Valuation

See full
Market cap$2.28B+134%
Enterprise value$2.47B+115%
P/S9.3×+3.8×

Profitability

See full
Gross margin70.5%+3.3pp
Operating margin-7.6%-3.4pp
Net margin-15.8%-6.4pp
FCF margin-16.9%-6.4pp

Returns & leverage

See full
Return on equity-175.3%-43.4pp
Debt / equity12.2×+2.1×
Current ratio3.8×+1.0×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Establishment Labs’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001688757-26-000050
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Accrued liabilities(1,727)646
Operating lease liabilities(512)(467)
Other liabilities(2,902)(1,178)
Net cash used in operating activities(20,912)(39,478)
Cash flows from investing activities:
Purchases of property and equipment(5,511)(2,377)
Cash used in business acquisitions, net of cash acquired(307)
Cost incurred for intangible assets(98)(723)

Item 1. Financial Statements - Unaudited

FAQ

What is Establishment Labs's operating cash flow?
Establishment Labs (ESTA) reported operating cash flow of -$16.6M in Q2 2026.
How has Establishment Labs's operating cash flow changed year-over-year?
Establishment Labs's operating cash flow increased by 11.5% year-over-year, from -$18.75M to -$16.6M.
What is the long-term trend for Establishment Labs's operating cash flow?
Over 4 years (2021 to 2025), Establishment Labs's operating cash flow has grown at a 16.6% compound annual growth rate (CAGR), from -$27.53M to -$50.89M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Establishment Labs's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude